ASPI
ASP Isotopes Inc.
NASDAQ · Basic Materials · Chemicals · US
$2.06
−3.97%Year over year
Reported trailing growth
- Revenue
- +573.4%
- EBITDA
- -30.7%
- EBIT
- —
- EPS
- +7.9%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +81.9%
- EBITDA
- +78.2%
- EPS
- +74.9%
Three-year CAGR
- Revenue
- +642.1%
- EBITDA
- —
- EBIT
- —
- Net income
- —
- EPS
- —
- Free cash flow
- -69.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026